The aortic stenosis market comprises devices that are used for the treatment of aortic valve stenosis, which is a common condition where the aortic valve narrows and does not open fully, making it difficult for the heart to pump blood to the rest of the body. Devices used in the treatment of aortic stenosis include surgical heart valves, transcatheter heart valves, and other accessories. Surgical heart valves are implanted via open-heart surgery, while transcatheter valves are implanted through a small incision or through catheter without opening the chest. Transcatheter aortic valve replacement (TAVR) procedures have gained immense popularity in recent years due to their minimally invasive nature and quick recovery time.
The Global aortic stenosis market is estimated to be valued at US$ 10.18 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the aortic stenosis market are Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, CryoLife, Inc., Braile Biom;dica, JenaValve Technology, Inc., Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, Inc., and egnite, Inc. Edwards Lifesciences dominates the market with a wide range of transcatheter heart valves.
The increasing prevalence due to aging population globally is expected to drive the Aortic Stenosis Market Demand. As per estimates, over 4 million people suffer from this condition worldwide. Furthermore, favorable reimbursement policies and growing awareness about minimal invasive treatment options are fueling the demand.
Geographic expansion through acquisitions and partnerships has helped major players strengthen their presence worldwide. For instance, Edwards Lifesciences has expanded its portfolio and global presence through the acquisitions of Transcatheter Technologies and Triton Medical in 2019.
Market Key Trends
One of the key trends expected to shape the aortic stenosis market outlook is the rising adoption of transcatheter aortic valve replacement (TAVR). TAVR procedures are preferred over open-heart surgeries due to advantages such as reduced hospital stay, lower risk of complications, and quicker recovery. Innovation in TAVR technologies with newer valve designs, delivery systems and sizes suitable for high-risk patients will drive the increased preference for TAVR. This is anticipated to significantly contribute to the revenue growth of the aortic stenosis market over the forecast period.
Porter’s Analysis
Threat of new entrants: The requirements for research, development and clinical trials for new treatments pose high barriers to entry for new companies.
Bargaining power of buyers: Individual patients have little influence on treatment choice and pricing due to the critical nature of the condition and reliance on physician recommendation.
Bargaining power of suppliers: Key technology and device manufacturers hold some power due to proprietary designs and patents, though competition maintains some competitive pressures.
Threat of new substitutes: No significantly safer or more effective substitutes currently exist, though research continues into alternatives like percutaneous valves.
Competitive rivalry: Major companies compete on innovative new products, though differentiation can be limited as technology matures and more competitors enter the space.
In terms of value, the aortic stenosis market is primarily concentrated in North America and Europe. Countries like the United States, Germany, France and the United Kingdom account for over 60% of the global market value currently.
The Asia Pacific region is expected to be the fastest growing market for aortic stenosis treatment over the forecast period. This is due to rising incidence rates associated with an aging population, increasing healthcare investments and expenditure capacity, and growing adoption of advanced treatment technologies in countries like China, India and Japan.
Get more insights on: - Aortic Stenosis Market
For Enhanced Understanding, Dive into the Report in the Language that Connects with You:-
- French
- German
- Italian
- Russian
- Japanese
- Chinese
- Korean
- Portuguese
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)